01 / DESIGN
What was studied?
Two small single-dose studies compared exposure across groups with different levels of renal or hepatic function.
02 / FINDINGS
What did the researchers report?
Exposure measurements showed no consistent pattern of clinically relevant differences across the studied impairment groups. No unexpected safety finding was identified in this limited setting.
03 / LIMITS
How should it be interpreted?
Small groups and single-dose observation cannot establish long-term safety. Pharmacokinetic similarity alone does not provide personal treatment advice or verify another formulation.
Voltera Peptide editorial reading note. Based on the linked source record. Methods and corrections.